GlassScriptPhysician profile
Grant V Chow
NPI 1184771701
$1,851.14
in general payments reported to CMS, 2019-2025
22 companies · $434 in 2025
The $434 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $91.20 · 2021: $187 · 2022: $319 · 2023: $273 · 2024: $358 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,065.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $363.06 | 2019-2025 | Carto 3 |
| Boston Scientific Corporation | $293.80 | 2019-2025 | Cds - Other, Bodyguardian, Cds - Mct/Cem Monitoring |
| Medtronic Vascular, INC. | $187.66 | 2019-2020 | |
| Atricure, INC. | $185.94 | 2022-2023 | |
| Medtronic, INC. | $122.22 | 2021-2025 | Micra, Symplicity G3 |
| Philips North America LLC | $109.00 | 2024-2025 | Igt Devices Undivided, (9278) Bridge |
| Pfizer INC. | $103.68 | 2022-2025 | |
| Amgen INC. | $84.20 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $82.06 | 2020-2023 | |
| Astrazeneca Pharmaceuticals LP | $46.39 | 2021-2023 | Farxiga, Brilinta |
| Angiodynamics, INC. | $39.82 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $29.70 | 2024 | Eliquis |
| Novartis Pharmaceuticals Corporation | $29.33 | 2023 | |
| Cordis US Corp. | $28.44 | 2024-2025 | Brite Tip Radianz, Mynx Control Venous |
| Janssen Pharmaceuticals, INC | $27.82 | 2021-2023 | Xarelto |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $27.53 | 2024 | Hemosphere |
| Heartflow, INC. | $25.63 | 2024 | |
| Abbott Laboratories | $17.82 | 2021 | |
| American Regent | $16.19 | 2023 | Injectafer |
| Elutia, INC. | $14.39 | 2023 | |
| Biotronik INC. | $12.14 | 2019 | |
| Altathera Pharmaceuticals LLC | $4.32 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.